These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1557907)

  • 1. Hemophilia--an ancient disease with new problems and new solutions.
    Rogers JS; Ritchey AK
    W V Med J; 1992 Feb; 88(2):50-3. PubMed ID: 1557907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in hemophilia.
    Tann G
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):218-28. PubMed ID: 524146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in care of children with hemophilia.
    Manco-Johnson MJ; Riske B; Kasper CK
    Semin Thromb Hemost; 2003 Dec; 29(6):585-94. PubMed ID: 14719175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration in hemophilia therapy selection.
    Pipe S
    Semin Hematol; 2006 Apr; 43(2 Suppl 3):S23-7. PubMed ID: 16631824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New prospects in the treatment of hemophilia. High-purity concentrates of factor VIII].
    Tusell Puigbert JM
    Med Clin (Barc); 1993 May; 100(17):655-8. PubMed ID: 8497171
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS and haemophilia.
    Bloom AL
    Biomed Pharmacother; 1985; 39(7):355-65. PubMed ID: 3938297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
    Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status and future prospects of hemophilia treatment].
    Lopaciuk S
    Acta Haematol Pol; 1995; 26(2 Suppl 1):44-55. PubMed ID: 7653234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate.
    Tsoukas C; Gervais F; Fuks A; Guttmann RD; Strawczynski H; Shuster J; Gold P
    Can Med Assoc J; 1983 Oct; 129(7):713-7. PubMed ID: 6225504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection in two brothers receiving intravenous therapy for hemophilia.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Apr; 41(14):228-31. PubMed ID: 1557013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.
    Remis RS; O'Shaughnessy MV; Tsoukas C; Growe GH; Schechter MT; Palmer RW; Lawrence DN
    CMAJ; 1990 Jun; 142(11):1247-54. PubMed ID: 2111726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral safety of plasma-derived factor VIII and IX concentrates.
    Ludlam CA
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
    Youjin S; Jun Y
    Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.